Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

Biopharmaceutical benchmarks

Nature Biotechnology volume 18, pages 831–833 (2000)Cite this article

Less than 20 years after the first biopharmaceutical, insulin, was approved, a new generation of products is superseding replacement proteins and enzyme therapies in biotechnology's pipeline.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. http://www.panmuregordon.com.

  2. Walsh, G. Biopharmaceuticals, biochemistry and biotechnology. (J. Wiley & Sons, Ltd., Chichester, UK; 1998).

    Google Scholar 

  3. http://www.phrma.org.

  4. http://www.eudra.org/en_home.htm

  5. Rohricht, P. Transgenic protein production; the technology and major players. Biopharm, March (1999), pp. 46–49.

  6. Rohricht, P. Transgenic protein production: process economics. Biopharm, September (1999), pp. 52–54.

  7. Colman, A. Dolly, Polly and other ‘ollys’: Likely impact of cloning technology on biomedical uses of livestock. Genet. Anal. Biomol. Eng. 15, 167–173 (1999).

    Article  CAS  Google Scholar 

  8. Dyer, M. et al. Functional genomics: from genes to new therapies. Drug Disc. Today 4, 109–114 (1999).

    Article  CAS  Google Scholar 

  9. Zweiger, G. Knowledge based discovery in gene expression microarray data; mining the information output of the genome. Trends Biotechnol. 17, 429–436 (1999).

    Article  CAS  Google Scholar 

  10. Wang, J. & Hewick, R. Proteomics in drug discovery. Drug Disc. Today 4, 129–133 (1999).

    Article  Google Scholar 

  11. Blackstock, W. & Weir, M. Proteomics: quantitative and physical mapping of cellular proteins. Trends Biotechnol. 17, 121–127 (1999)

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. lecturer, Industrial Biochemistry Programme, University of Limerick, Ireland

    Gary Walsh

Authors
  1. Gary Walsh
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Walsh, G. Biopharmaceutical benchmarks. Nat Biotechnol 18, 831–833 (2000). https://doi.org/10.1038/78720

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/78720

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing